ScienceGate Book Chapters

JOURNAL ARTICLE

Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia

Akriti Jain Virginia O. Volpe Chen Wang Somedeb Ball Katherine Tobon Onyee Chan Eric Padron Andrew Kuykendall Jeffrey E. Lancet Rami S. Komrokji David A Sallman Kendra Sweet

Year: 2024 Journal: Annals of Hematology Vol: 104 (1)Pages: 307-315 Publisher: Springer Science+Business Media

DOI: 10.1007/s00277-024-05976-6

Get Full-Text PDF Get Analytical Report

Keywords:

Venetoclax Myeloid leukemia Hypomethylating agent Medicine Hematology Internal medicine Oncology Leukemia Azacitidine Myeloid Biology Genetics Chronic lymphocytic leukemia Gene

Metrics

2

Cited By

1.93

FWCI (Field Weighted Citation Impact)

14

Refs

0.79

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Acute Myeloid Leukemia Research

Health Sciences → Medicine → Hematology

Myeloproliferative Neoplasms: Diagnosis and Treatment

Health Sciences → Medicine → Genetics

Acute Lymphoblastic Leukemia research

Health Sciences → Medicine → Public Health, Environmental and Occupational Health

Related Documents

JOURNAL ARTICLE

Outcomes By Best Response with Hypomethylating Agent Plus Venetoclax in Adults with Previously Untreated Acute Myeloid Leukemia

Virginia O. Volpe Akriti Jain Onyee Chan Eric Padron David A. Sallman Rami S. Komrokji Jeffrey E. Lancet Kendra Sweet

Journal: Blood Year: 2021 Vol: 138 (Supplement 1)Pages: 2292-2292

JOURNAL ARTICLE

Characteristics and outcomes in Acute Myeloid Leukemia with Mecom rearrangement treated with hypomethylating agent plus venetoclax

Leora Boussi Elizabeth Corley Andriy Derkach Alexander J. Ambinder Somedeb Ball Stephen W. Chung Kateryna Fedorov Ashwini Yenamandra Emily F. Mason Bang H. Hoang Christopher Famulare Meira Yisraeli Salman Justin C. Wheat Meghan C. Thompson Sheng F. Cai Eytan M. Stein Yanming Zhang Aaron D. Goldberg

Journal: Blood Year: 2025 Vol: 146 (Supplement 1)Pages: 1616-1616

JOURNAL ARTICLE

AML-1357: Outcomes in Acute Myeloid Leukemia With MECOM Rearrangement (MECOMr-AML) Treated With Hypomethylating Agent Plus Venetoclax

Leora Boussi Elizabeth Corley Andriy Derkach Meira Yisraeli Salman Justin C. Wheat Christopher Famulare Kuo‐Kai Chin Meghan C. Thompson Sheng F. Cai Eytan M. Stein Yanming Zhang Aaron D. Goldberg

Journal: Clinical Lymphoma Myeloma & Leukemia Year: 2025 Vol: 25 Pages: S503-S503

JOURNAL ARTICLE

Outcomes of Adults Treated with a Hypomethylating Agent Plus Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia: A Multicenter Retrospective Study

Emily Geramita Hong Wang Melissa Bastacky Jessica B Cohen Rory M. Shallis Talha Badar Mark R. Litzow Annie Im

Journal: Blood Year: 2022 Vol: 140 (Supplement 1)Pages: 6187-6188

JOURNAL ARTICLE

Abstract 5960: Outcomes of acute myeloid leukemia treated with a hypomethylating agent and venetoclax

Markie Zimmer Brigid Jacob Mikayla Spica Sunita Ghosh Vrushali Dabak

Journal: Cancer Research Year: 2025 Vol: 85 (8_Supplement_1)Pages: 5960-5960